Cumberland Pharma says ifetroban Phase 2 DMD extension data not ready, pulls August 2026 timing
CPIX•Guidance on extension data timing
Cumberland corrected guidance on when it expects to release long-term safety and efficacy data from its Phase 2 FIGHT DMD open-label extension.
A conference slide indicated the data was expected in August 2026.
The company said the data is not yet available, no longer expects an August 2026 presentation, and will present it later.
